0.04% -0.02

Soleno Therapeutics Inc (SLNO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	68.76% 23.48	13.91	10.38	8.623	8.469
Depreciation and Amortization	0.20% 0.49	0.489	0.49	0.489	0.49
Operating Income/Loss	68.76% -23.48	-13.91	-10.38	-8.623	-8.469
Nonoperating Income/Loss	20.54% 2.077	2.614	-0.479	0.148	0.113
Income/Loss From Continuing Operations Before Tax	89.43% -21.40	-11.30	-10.86	-8.475	-8.356
Income/Loss From Continuing Operations After Tax	89.43% -21.40	-11.30	-10.86	-8.475	-8.356
Net Income/Loss	89.43% -21.40	-11.30	-10.86	-8.475	-8.356
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	498.59% 36.21	6.0489	11.44	10.42	9.4474
Diluted Average Shares	498.59% 36.21	6.0489	11.44	10.42	9.4474
Basic Earnings Per Share	303.45% -0.59	0.29	-0.95	-0.81	-0.88
Diluted Earnings Per Share	303.45% -0.59	0.29	-0.95	-0.81	-0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%